Lutein, zeaxanthin, and meso-zeaxanthin are three carotenoids that are specifically concentrated in the human macula. Lutein and zeaxanthin are obtained through dietary sources, such as green leafy vegetables and orange and yellow fruits and vegetables, while meso-zeaxanthin is uncommon in diet and is formed at the macula by metabolic processes of ingested carotenoids.
These carotenoids are widely recommended as dietary supplements for the prevention of two most common eye diseases in older people, that is, cataract and macular degeneration.
The growth of the lutein and zeaxanthin market is attributed to the rise in the prevalence of eye disorders such as age-related macular degeneration, and skin disorder. Also, the increase in strategic initiatives such as mergers, collaborations, and acquisitions, by leading players is expected to provide favorable environment for the growth of the market.
According to the report, the global lutein and zeaxanthin market was estimated at $397,606.1 thousand in 2021, and is anticipated to hit $627,779.55 thousand by 2031, registering a CAGR of 4.9% from 2022 to 2031.
Increase in number of skin cancer cases due to UV radiation has led to an increased demand for lutein and zeaxanthin-containing skin care products, which has driven the global lutein and zeaxanthin market. On the other hand, certain factors such as stringent rules and regulations associated with nutraceuticals impede the growth to some extent. However, growing interest of the key players in the pharmaceutical industry toward nutraceuticals products has paved the way for lucrative opportunities for the key players in the industry.
